Skip to main content

Table 4 Medians with the first and third quartiles in parentheses, and ranges in brackets, of the nine parameters, in the exudate and transudate group, respectively.

From: The diagnostic role of glycosaminoglycans in pleural effusions: A pilot study

 

Exudates (n = 45)

Transudates (n = 5)

p

pGAG

14.4 (10.4–21.3), [4.0–59.7]

4.9 (3.9–7.2), [3.3–8.4]

< 0.001

sGAG

8.0 (6.6–9.8), [2.3–23.0]

8.6 (6.6–13.0), [5.5–16.4]

0.571

GAGR

1.9 (1.1–2.9), [0.5–8.6]

0.5 (0.3–1.1), [0.3–1.1]

0.001

pTP

4.2 (3.4–5.0), [1.6–6.1]

2.6 (2.1–2.7), [1.6–2.8]

< 0.001

sTP

6.5 (5.8–7.1), [4.7–8.6]

6.3 (5.0–6.7), [4.8–7.0]

0.267

TPR

0.6 (0.6–0.7), [0.3–2.0]

0.4 (0.3–0.5), [0.2–0.5]

0.001

pLDH

331.0 (195.0–596.0), [73–7000]

103.0 (66.5–144.5), [63–177]

< 0.001

sLDH

225.0 (200.5–324.5), [129–1018]

262.0 (237.0–267.5), [214–272]

0.550

LDHR

1.3 (0.7–2.0), [0.3–9.5]

0.4 (0.3–1.0), [0.2–0.7]

< 0.001

  1. For each parameter, comparisons between the two groups were made to establish statistically significant differences.